Research boards - Areas of funding
This table matches an area of research with the research board that oversees competitions in that area.
Area |
Board |
The development and evaluation of healthcare interventions |
New arrangements for large clinical trials through the Efficacy and Mechanisms Evaluations programme, and new arrangements for Global Health Trials. (Evaluations of existing health technologies will be funded from the health technology assessment programmes). |
Population-based aetiological studies, which consider the factors involved in disease progression with particular emphasis on environmental and psychosocial factors |
Now embedded across new board remits. Core funding for cohorts addressing multiple conditions / processes is now covered by MCMB; research into specific processes or diseases will be supported by the appropriate Boards (IIB, NMHB and PSMB). |
Implementation studies, which look at how to put research findings into practice |
Methodology Programme and across the boards |
Methodological developments - the study of methods that underpin health research |
|
Virology, bacteriology and parasitology of human pathogens, zoonoses, model infectious agents and vectors of infectious agents |
Infections and Immunity Research Board (IIB) |
Human immunology including studies in humans and informative models |
IIB |
Molecular, cellular and systems research into mechanisms of susceptibility, immunity, inflammation, immune tolerance and rejection, pathogenesis, resistance and physiology |
IIB |
Discovery research and early stage development of diagnostics, vaccines, immunotherapeutics and vaccines in vitro, including structural biology, animal models and early studies in humans |
IIB |
Population-level research, using mathematical, epidemiological, genetic and genomic designs, to elucidate disease risks, aetiologies and progression, and to understand the evolution of pathogen populations |
IIB |
Research to inform novel strategies for preventing and controlling infectious and immune disease control, including research on human behaviour and lifestyle |
IIB |
Global infections |
IIB |
Basic neurobiology (for example, molecular and cell biology and developmental neurobiology) |
Neurosciences and Mental Health Board (NMHB) |
Systems-based neuroscience research |
NMHB |
Senses and cognition and behavioural neuroscience |
NMHB |
Pain, pain relief and anaesthesia |
NMHB |
Medically relevant psychology |
NMHB |
Neuroimaging |
NMHB |
Dementia, neurodegenerative disease, transmissible spongiform encephalopathies and other areas of neurology |
NMHB |
Mental health, addictions and psychiatry |
NMHB |
Cell biology |
Molecular and Cellular Medicine Board (MCMB) |
Structural biology and biophysics |
MCMB |
Developmental and stem cell biology (excluding neurobiology) |
MCMB |
Molecular haematology |
MCMB |
Chemical biology |
MCMB |
Bioinformatics |
MCMB |
Cancer (includes basic biology, translational research and epidemiology) |
MCMB |
Genetic mechanisms and genomics |
MCMB |
Toxicology |
MCMB |
Environmental factors (toxins, radiation etc) affecting health |
MCMB |
Pharmacology |
MCMB |
Regenerative medicine |
MCMB |
Nanotechnology and applications of other new technologies to biomedicine |
MCMB |
Method development for gene therapy |
MCMB |
Function and pathophysiology, and prevention or treatment of deterioration or illness, in the all the major organ systems (except the brain), including: cardiovascular system, musculoskeletal system, gastrointestinal system, respiratory system, endocrine system, reproductive system |
Population and Systems Medicine Board (PSMB) |
Nutrition, energy metabolism, obesity, molecular medicine and genetic aspects of health and disease. |
PSMB |
Diabetes |
PSMB |
Ageing and lifelong health |
PSMB |
Maternal health and the early origins of health and disease. |
PSMB |
Trauma, acute medicine and surgery |
PSMB |
Medical sociology |
PSMB |
Lifestyle, socio-economic and behavioural impacts on general health and health inequalities |
PSMB |